March 25, 2020 News by Patricia Inacio, PhD ‘Talk’ Therapy Helps with Insomnia and Fatigue in MS, Trial Suggests Cognitive behavioral therapy, a type of “talk” therapy, may help ease the severity of insomnia, fatigue, and anxiety in people with multiple sclerosis (MS), improving the quality of their sleep, data from a single-site trial suggest. The study “Feasibility and Treatment Effect of Cognitive Behavioral Therapy for Insomnia…
February 17, 2020 News by Iqra Mumal, MSc Insomnia and MS Given Intimate Focus in Short Film ‘Awake’ by UK Group Insomnia, and all that repeat sleepless nights mean, burden a vast majority — 85% — of people with multiple sclerosis (MS), a survey of patients who are part of the Shift.MS social network in the U.K. reports. The online community of more than 30,000 people examines this symptom in…
November 21, 2019 Columns by Jennifer (Jenn) Powell Painsomnia Unravels Me from Inside Out It is 2 a.m. and I am awake. I sit on the couch with my head in my hands. The leg pain that broke my slumber is now extreme. I have taken my medications, used my topical, and applied heat. All to no avail. Exhaustion meets pain as my eyes…
October 4, 2018 Columns by Jennifer (Jenn) Powell MS-related Insomnia is Exhausting I do not sleep well. Ever. I have tried a myriad of meditations and medications, yet sleep evades me. It is 2:30 a.m. and infomercials are taking over the airwaves. My knowledge of everything Ginsu knives is overrated. (Pro tip: If you wait until the end they always offer…
March 29, 2024 by BioNews Staff We love each other, but we hate multiple sclerosis Day 29 of 31 This is Mike and Jenn Powell’s story, as a conversation: Jenn and Mike Powell stand with their dog, Skye, in Laguna Beach in November 2023. (Photo by Vicki Shequin) Jenn Powell: My husband, Mike, hates multiple sclerosis (MS). There was a…
October 27, 2023 News by Lindsey Shapiro, PhD Study examines real-world side effects linked to dalfampridine The most common real-world side effects linked to dalfampridine — sold as Ampyra and with generics available — are similar to those listed on its prescribing label for multiple sclerosis (MS), according to data from a safety surveillance database. Common side effects included urinary tract infection (UTI), dizziness…
April 11, 2023 News by Margarida Maia, PhD Lemtrada aids cognitive skills, eases depression in real-world MS study One year of treatment with Lemtrada (alemtuzumab) significantly improved cognitive abilities, particularly with processing speed, and eased depression in people with relapsing forms of multiple sclerosis (MS), a small real-world study reported. Most of the 39 patients (92%) evaluated after that treatment year showed either stable or improved…
April 4, 2023 News by Margarida Maia, PhD CHMP favors Briumvi for approval to treat relapsing forms of MS in EU An arm of the European Medicines Agency favors the approval of Briumvi (ublituximab) to treat adults with active, relapsing forms of multiple sclerosis (MS) across the European Union (EU). The Committee for Medicinal Products for Human Use (CHMP) opinion is based on data from twin Phase 3 trials,…
March 28, 2023 News by Andrea Lobo, PhD Sleep disorders in MS women may be factor in cognitive decline: Study Note: This story was updated March 29, 2023, to correct that cognitive function was assessed via questions about memory and three other cognition outcomes. Sleep disorders such as insomnia, sleep apnea, and sleepiness may contribute to self-reported cognitive decline in women with multiple sclerosis (MS), a new study suggests.
March 10, 2023 by BioNews Staff 31 Days of MS: Getting a second chance at life, thanks to HSCT Photo courtesy of Cassidy V. Chapman Day 10 of 31 This is Cassidy V. Chapman’s story: I was diagnosed with relapsing-remitting multiple sclerosis in January 2004 at the age of 22, the day before my 23rd birthday. It happened during my first year of law school. Still,…
March 3, 2023 Columns by Ed Tobias Let’s talk about MS fatigue and the effectiveness of treatment options Want to reduce your multiple sclerosis (MS) fatigue? Maybe we should talk about it. I’m talking about a fatigue treatment called cognitive behavioral therapy (CBT), which usually involves changing a person’s thinking and behavior. By talking with a therapist, sometimes on the phone, a patient develops an…
January 6, 2023 Columns by Ed Tobias FDA Approval of Ublituximab, Now Briumvi, Is Good News The new year is bringing a new disease-modifying therapy (DMT) to the multiple sclerosis (MS) arsenal. Shortly after Christmas, the U.S. Food and Drug Administration (FDA) approved Briumvi (ublituximab), which joins a small group of DMTs that aim to halt MS progression by knocking out certain…
December 28, 2022 News by Lindsey Shapiro, PhD Ublituximab, Now Briumvi, Approved in US for Relapsing Forms of MS The U.S. Food and Drug Administration has approved TG Therapeutics‘ B-cell-depleting therapy ublituximab under the brand name Briumvi for the treatment of adults with relapsing forms of multiple sclerosis (MS), the company announced. The approval covers clinically isolated syndrome, relapsing-remitting MS (RRMS), and active secondary progressive…
November 3, 2022 Columns by Benjamin Hofmeister Relief From Multiple Sclerosis Sleep Disorders Is a Dream Multiple sclerosis (MS) and a good night’s sleep seem to be mutually exclusive. I seriously doubt that anyone with MS will reply in the comments that the disease has blessed them with the best sleep of their lives. Yet I used the word “seem” because when writing about any…
October 12, 2022 by BioNews Staff Expert Voices: How to sleep well with multiple sclerosis In this installment of our “Expert Voices” series, Multiple Sclerosis News Today asked Alexa Kane, MD, to answer some of your questions about how sleep affects multiple sclerosis (MS) and vice versa. Kane is a clinical health psychologist at the Cleveland Clinic Mellen Center for Multiple Sclerosis for Treatment…
July 11, 2022 News by Marisa Wexler, MS Early MS Symptoms May Help Predict Diagnosis, Disease Course Some prodromal symptoms of multiple sclerosis (MS) — symptoms that are evident before the disease begins in earnest — could help to predict the course of MS, a new study proposes. In particular, its researchers suggest that MS patients with prodromal depression are more likely to be diagnosed…
June 2, 2022 News by Vanda Pinto, PhD Pandemic’s Negative Aspects Tied to Worse Disability in MS Patients Worsening disability was associated with worry about COVID-19 in people with multiple sclerosis (MS) living in the U.S. and Italy, a study evaluating the pandemic’s impact has found. In both countries, MS patients with greater psychological disabilities, such as depression, were more likely to have worrying thoughts, while those…
May 11, 2022 News by Marta Figueiredo, PhD Low Levels of APP Molecule Found in Patients With MS-related Fatigue Multiple sclerosis (MS) patients with fatigue have significantly lower levels of amyloid precursor protein (APP) — a molecule involved in nerve cell function — in the cerebrospinal fluid (CSF) relative both to those without this common symptom and healthy people, a study shows. The CSF is the liquid…
March 2, 2022 Columns by Beth Ullah The Double-edged Sword of Fatigue Medications “I close my eyes/ Only for a moment then the moment’s gone/ All my dreams pass before my eyes, a curiosity.” — Kansas, “Dust in the Wind” The dark cloud of fatigue first swept through my mind toward the end of 2018. I was no stranger to physical fatigue,…
January 26, 2022 Columns by Beth Ullah The Trials and Tribulations of MS Medications “Hey, man, I’m alive. I’m taking each day and night at a time/ I’m feeling like a Monday but someday I’ll be Saturday night.” — Bon Jovi Multiple sclerosis (MS) medications can generally be separated into two categories: disease-modifying therapies (DMTs) and those that help to manage symptoms. While…
January 14, 2022 by BioNews Staff Expert Voices: Complementary and alternative medicine for multiple sclerosis In this installment of our “Expert Voices” series, Multiple Sclerosis News Today asked Allen C. Bowling, MD, PhD, to answer some of your questions related to complementary and alternative medicine (CAM) for people with multiple sclerosis (MS). Bowling is an internationally recognized neurologist and integrative medicine pioneer with…
December 31, 2021 News by Margarida Maia, PhD Cognition-targeted Exercise May Boost CBT’s Easing of Fatigue Cognition-targeting exercise, when combined with cognitive behavioral therapy (CBT) — a type of talk therapy — may further ease fatigue and other symptoms in people with multiple sclerosis (MS), a study found. The study, “The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized…
December 6, 2021 News by Margarida Maia, PhD OTC Melatonin Improves Sleep Quality in MS Patients, Trial Finds Taking the hormone melatonin may increase overall sleep quality in people with multiple sclerosis (MS), a clinical trial found. The compound, available as an over-the-counter dietary supplement, was particularly effective at extending sleep time in patients. Of note, sleep time decreased with age, meaning that “younger participants may have…
September 23, 2021 Columns by Jennifer (Jenn) Powell Emotional and Physical Pain Are My Unwanted Sidekicks Pain is the consummate four-letter word. I have felt pain in the most primal of ways. The emotional chasm of grief in my soul. The physical torture of pain in my body. Pain is unyielding in its relentless torment. It remains the quagmire I fail to solve. Life with…
September 9, 2021 News by Steve Bryson, PhD ADS-5102 Aided Walking Speed in Select MS Patients in INROADS Trial An extended-release formulation of amantadine, ADS-5102 was significantly more effective than a placebo at increasing walking speed in multiple sclerosis (MS) patients who had difficulty with this, particularly younger patients with a shorter disease course, the INROADS Phase 3 trial demonstrated. Further clinical work on this investigative…
August 26, 2021 Columns by Jennifer (Jenn) Powell When Restless Legs Syndrome Won’t Leave You Alone The light of the television screen illuminates the darkness. I want so much to sleep, but my body has other plans. After a hot shower and multiple medications, my legs continue to dance. The constant ache, twitch, and kick are a rhythmic routine. But my body is tired and…
August 9, 2021 News by Marisa Wexler, MS US Survey Finds High Rates of Dissatisfaction With Quality of Life, But Satisfaction With Healthcare More than one-third of people with multiple sclerosis (MS) who responded to an online U.S.-based survey are dissatisfied with their quality of life, and more than one in four MS patients are pessimistic about their future, according to the results of the survey, conducted by Multiple Sclerosis News…
July 29, 2021 Columns by Jennifer (Jenn) Powell MS Doesn’t Get to Decide Whether We Are Enough “Change is the only constant in life,” a quote paraphrased from Greek philosopher Heraclitus states. This ancient wisdom still prevails today. Life is in a constant flux. We evolve, we grow, and we shift, and we are never the same. When I suffer, I cling to this knowledge. And…
July 22, 2021 Columns by Jennifer (Jenn) Powell Are You Prepared for a Fall? I sit amid the flood of carpet stain remover. My left leg is elongated as my right leg is at a jackknife. The cool of the fluid penetrates my sweats. Shock dissipates into pain. I try to move, but pain sears down toward my tailbone. I sit in the dark…
June 16, 2021 News by Margarida Maia, PhD Stopping Cannabis Aids Cognition in MS, But Not Awareness of Gains People with multiple sclerosis (MS) may not be entirely aware of the decline in their cognitive abilities with cannabis use, which may explain why many choose to continue with it, a small study in patients who are long-term cannabis users reported. The study, “Impaired awareness: Why people with…